Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection
- 1 November 1997
- journal article
- case report
- Published by Elsevier in Journal of Infection
- Vol. 35 (3) , 295-297
- https://doi.org/10.1016/s0163-4453(97)93270-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Detection and Significance of Fluconazole Resistance in Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected PatientsThe Journal of Infectious Diseases, 1996
- Azole drug resistance in yeastsJournal of Antimicrobial Chemotherapy, 1995
- Nosocomial Candidemia: Risk Factors and Attributable MortalityClinical Infectious Diseases, 1995
- Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patientsJournal of Antimicrobial Chemotherapy, 1995
- Emergence of azole drug resistance in Candida species from HIV-infected patients receivingprolonged fluconazole therapy for oral candidosisJournal of Antimicrobial Chemotherapy, 1995
- Isolation of Fluconazole-Resistant Candida albicans from Human Immunodeficiency Virus-Negative Patients Never Treated with AzolesClinical Infectious Diseases, 1995
- Management of deepCandida infection in surgical and intensive care unit patientsIntensive Care Medicine, 1994
- Candidemia in a Tertiary Care Hospital: Epidemiology, Risk Factors, and Predictors of MortalityClinical Infectious Diseases, 1992
- Fluconazole Treatment of Catheter-Related Right-Sided Endocarditis Caused by Candida albicans and Associated with Endophthalmitis and FolliculitisClinical Infectious Diseases, 1992
- In-vitro resistance to imidazole antifungals in Candida albicansJournal of Antimicrobial Chemotherapy, 1984